Venus Remedies Stock Price Analysis and Quick Research Report. Is Venus Remedies an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Venus Remedies. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Venus Remedies has a PE ratio of 22.7996500437445 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Venus Remedies has ROA of 7.7615% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Venus Remedies has a Current ratio of 4.1408.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Venus Remedies has a ROE of 9.5736%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Venus Remedies has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Venus Remedies has reported revenue growth of 11.17% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Venus Remedies for the current financial year is 10.9464540364058%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Venus Remedies is Rs 0 and the yield is 0.5827%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Venus Remedies is Rs 74.295. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Venus Remedies in Ticker for free. Also, one can get the intrinsic value of Venus Remedies by using Valuation Calculators, which are available with a Finology ONE subscription. 

Venus Remedies FAQs

Q1. What is Venus Remedies share price today?
Ans: The current share price of Venus Remedies is Rs 1693.9.

Q2. What is the market capitalisation of Venus Remedies?
Ans: Venus Remedies has a market capitalisation of Rs 2264.23409732 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Venus Remedies?
Ans: The PE ratio of Venus Remedies is 22.7996500437445 and the P/B ratio of Venus Remedies is 3.28327369853349, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Venus Remedies share?
Ans: The 52-week high share price of Venus Remedies is Rs 2044.3, and the 52-week low share price of Venus Remedies is Rs 424.

Q5. Does Venus Remedies pay dividends?
Ans: Currently, Venus Remedies pays dividends. Dividend yield of Venus Remedies is around 0.5827%.

Q6. What are the face value and book value of Venus Remedies shares?
Ans: The face value of Venus Remedies shares is Rs 10, while the book value per share of Venus Remedies is around Rs 515.918. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Venus Remedies?
Ans: Venus Remedies has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Venus Remedies?
Ans: The ROE of Venus Remedies is 9.5736% and ROCE of Venus Remedies is 13.9123%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Venus Remedies a good buy for the long term?
Ans: The Venus Remedies long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Venus Remedies undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Venus Remedies appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Venus Remedies’s financials?
Ans: You can review Venus Remedies’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.